Using Bremelanotide Intranasal Spray To Treat HSDD

The food and drug administration in the United States approved Bremelanotide to treat women’s sexual health problems like low sexual desire in women before menopausal. So bremelanotide is used to treat generalized hypoactive sexual desire disorder or acquired hypoactive sexual desire disorder. Bremelanotide is sold under the name Vyleesi.

Hypoactive sexual desire disorder (HSDD) is a condition that is marked not only by low sexual desire but also by distress, relationship difficulties, mental health conditions, etc. Generalized Hypoactive sexual desire disorder develops in women that experience problems with their sexual desire regardless of the situation, partner, and type of sexual activity. Whereas, acquired hypoactive sexual desire disorder occurs in women who did not face any kind of sexual desire problems before in life.

Vyleesi or bremelanotide intranasal spray helps to activate the melanocortin receptors in women. These receptors are used to improve sexual desire in women. Bremelanotide intranasal spray is only to be used to treat low sexual desire that is caused under particular sexual circumstances, with a particular sex partner, or any type of sexual activity. It must not be confused with low sexual desire due to menopause, relationship problems, health conditions, drug abuse, medications, etc. Also, keep in mind that bremelanotide should not be used to improve performance during sex.

Dosage of bremelanotide intranasal spray

The dosage of bremelanotide intranasal spray depends upon the intensity of symptoms and the health condition of the patient. The spray contains 21 mg or 0.3 ml of contents. It must be taken about 45-60 mins before having any kind of sexual activity through a nostril. It is generally prescribed not to take more than one bremelanotide dose within a day and no more than 8 doses in a month.

Effects of bremelanotide

The common effects of using bremelanotide nasal spray include:

     Nausea

     Hot flashes

     Cough

     Flu

     Dizziness

     Tiredness

     Headache

DO NOT USE

     If you have cardiovascular or blood pressure issues

     During pregnancy

     During breastfeed

Comments

  1. Bremelanotide Nasal Spray has been clinically studied in women with acquired, generalized hypoactive sexual desire disorder (HSDD), as characterized by low sexual desire that causes marked distress or interpersonal difficulty that is NOT due to: A co-existing medical or psychiatric condition.

    ReplyDelete

Post a Comment

Popular posts from this blog

What Do You Need To Know About Migraines?

Rejuvenate Your Skin, Get Rid of Wrinkles

In what ways post-menopausal women can benefit from HRT